Pasquale Striano
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (13)
Background: Although home births provide personal and intimate experiences, they pose potential risks that may be better managed in hospital settings. The safety of home birth remains highly debated, with no consensus on its safety or potential adverse events, and its adoption varies widely across the world. In Italy, the Italian Society of Neonatology opposed this practice, resulting in one of the lowest home birth rates in Europe (approximately 0.1% of total births). This study evaluated the impact of planned home births on neonatal health, with a focus on severe complications requiring intervention in the pediatric emergency department (PED). Methods: Cases were collected from patients admitted to IRCCS Istituto Giannina Gaslini Children’s Hospital between January 2022 and December 2024. The analysis focused on neonates born at home, who required emergency care for life-threatening conditions. Results: We identified five cases, with an incidence of approximately 0.65 per 10,000 PED visits and a complication rate of 15–30% for all planned home births. Factors contributing to unfavorable outcomes include lack of advanced medical equipment, timely diagnostics, and comprehensive postpartum screening. Thus, while proponents argue that home births can provide a more comfortable and personalized experience, concerns about safety and associated risks persist. Conclusions: This study aims to highlight the necessity of adopting hospital-level neonatal care protocols for home births, particularly during the critical first 48 h of life, to mitigate risks and ensure optimal neonatal outcomes.
Year:
2025
Sunflower syndrome, a rare photosensitive epilepsy characterized by handwaving episodes and fixation on light sources, remains poorly understood, especially regarding its neuropsychological profile. This study provides a detailed cognitive evaluation of two patients, revealing a likely disruption in the visual dorsal stream, with particular involvement of the ventral attention network (VAN). Despite normal overall intellectual functioning, both patients exhibited significant deficits in Processing Speed Index and inhibitory control, indicating selective executive dysfunction. Coupled with EEG anomalies predominantly in the right frontal lobe, these findings suggest right hemisphere involvement, potentially along the VAN pathway. This study highlights the need for further research, particularly functional neuroimaging, to better understand the neurocognitive aspects of sunflower syndrome and its impact on patients' quality of life.
Year:
2025
A bstract Temporal lobe epilepsy with hippocampal sclerosis (TLE-HS) is associated with a complex genetic architecture, but the translation from genetic risk factors to brain vulnerability remains unclear. Here, we examined associations between epilepsy-related polygenic risk scores for HS (PRS-HS) and brain structure in a large sample of neurotypical children, and correlated these signatures with case-control findings in in multicentric cohorts of patients with TLE-HS. Imaging-genetic analyses revealed PRS-related cortical thinning in temporo-parietal and fronto-central regions, strongly anchored to distinct functional and structural network epicentres. Compared to disease-related effects derived from epilepsy case-control cohorts, structural correlates of PRS-HS mirrored atrophy and epicentre patterns in patients with TLE-HS. By identifying a potential pathway between genetic vulnerability and disease mechanisms, our findings provide new insights into the genetic underpinnings of structural alterations in TLE-HS and highlight potential imaging-genetic biomarkers for early risk stratification and personalized interventions.
Year:
2025
(1) Background: The first 1000 days of life constitute a critical window of opportunity for microbiota development. Nutrients play a crucial role in enriching and diversifying the microbiota, derived not only from solid food but also from maternal dietary patterns during gestation. (2) Methods: We conducted a comprehensive literature review using the PubMed database, covering eleven years (2013–2023). We included English-language reviews, original research papers, and meta-analyses, while excluding case reports and letters. (3) Results: Consensus in the literature emphasizes that our interaction with a multitude of microorganisms begins in the intrauterine environment and continues throughout our lives. The existing data suggest that early nutritional education programs, initiated during pregnancy and guiding infant diets during development, may influence the shaping of the gut microbiota, promoting long-term health. (4) Conclusions: Further research is necessary in the coming years to assess potential interventions and early nutritional models aimed at modulating the pediatric microbiota, especially in vulnerable populations such as premature newborns.
Year:
2024
Objective This study was undertaken to characterize the clinical and genetic features of patients with 22q11.2 deletion syndrome (22q11.2DS) and generalized epilepsy compared with 22q11.2DS individuals without epilepsy. Methods This multicenter case–control study included 28 patients with 22q11.2DS‐related generalized epilepsy and compared their data with 56 age‐matched 22q11.2DS controls without epilepsy. Clinical and electroencephalographic features, neuropsychiatric and systemic comorbidities, family history of epilepsy, and genetic findings were collected. Results Generalized tonic–clonic seizures and myoclonic seizures were the most common electroclinical presentations, with a broader range of seizure type combinations also documented. Most patients achieved seizure remission with antiseizure medications, with only 4% exhibiting drug resistance. A higher prevalence of family history of epilepsy was observed among patients with 22q11.2DS‐related generalized epilepsy compared to nonepilepsy controls, even when limiting the analysis to patients with known de novo deletions. No differences in deletion size or location were observed between the groups. Multivariable logistic regression analysis identified family history of epilepsy, intellectual disability, and lack of skeletal abnormalities as independent factors associated with generalized epilepsy, whereas a history of psychosis was significant only in univariable analysis. Significance This study provides a detailed characterization of generalized epilepsy in individuals with 22q11.2DS and highlights specific associated comorbidities. The higher prevalence of family history of epilepsy among cases suggests that genetic factors beyond the 22q11.2 deletion influence the development of the epilepsy phenotype, providing new insights into the genetic underpinnings of phenotypic variability in this syndrome.
Year:
2024
Background: Human milk (HM) is recognized as an ideal source of nutrition for newborns; as a result, its multiple bioactive molecules can support the growth of healthy newborns and reduce the risk of mortality and diseases such as asthma, respiratory infections, diabetes (type 1 and 2), and gastrointestinal disorders such as ulcerative colitis and Crohn’s disease. Furthermore, it can reduce the severity of necrotizing enterocolitis (NEC) in preterm infants. Moreover, human milk oligosaccharides (HMOs) present in breast milk show an immunomodulatory, prebiotic, and neurodevelopmental effect that supports the microbiota–gut–brain axis. Material and methods: This study examined the state-of-the-art research, using keywords such as “breastfeeding”, “human milk oligosaccharides”, “microbiota–gut–brain axis”, “infants”, and “malnutrition”. The literature review was conducted by selecting articles between 2013 and 2024, as the most recent ones. The databases used were Web Science, PubMed, and Scopus. Results: We found multiple studies examining the composition of HM and infant formula (IF). However, further longitudinal studies and randomized control trials (RCTs) are needed to better understand the clinical outcomes that bioactive components exert on healthy and hospitalized children and how, in conditions of malnutrition, it is necessary to support the growth of the newborn. Conclusions: In this review, we affirm the importance of human milk and, through it, the modulation of the microbiota and the neuroprotective role in newborns, determining the health of the following years of life.
Year:
2024
Objective Cenobamate (CNB), a recently approved antiseizure medication by the European Medicines Agency (EMA), serves as an adjunctive therapy for focal‐onset seizures in adult patients unresponsive to at least two other treatments. Administered in polytherapy, CNB can potentially interact with co‐administered drugs in epilepsy patients, necessitating dose adjustments and the need for effective therapeutic drug monitoring (TDM). Methods In this study, we introduce a novel LC–MS/MS method for precise CNB quantification using Volumetric Absorptive Microsampling (VAMS), following validation according to ICH guidelines M10. VAMS samples are efficiently extracted with 200 μL of methanol, with chromatographic separation achieved using an Acquity UPLC HSS PFP column. The method's efficacy was confirmed through its application to real samples from adult CNB‐treated patients. Results Our results demonstrate that the method exhibits linearity within the range of 0.05–30 mg/L, with intra‐ and inter‐run precision ranging from 1% to 8% and accuracy from 1% to 10% based on 30 μL of sample. Furthermore, CNB stability in VAMS is confirmed for up to 15 days at 25°C and −20°C. Importantly, no significant difference was observed between CNB concentrations in VAMS samples and those in plasma obtained from venous blood. Significance This VAMS‐based LC–MS/MS method presents a robust alternative for TDM in CNB‐treated patients. Future investigations should explore CNB concentrations in capillary blood and assess their correlation with plasma levels to further enhance its clinical utility. Plain Language Summary Cenobamate is an antiepileptic drug and used for treatment of focal‐onset seizures in adult patients (≥18 age). TDM can prevent drug interactions and minimize drug toxicity. The aim of this work is to evaluate volumetric absorptive microsampling (VAMS) from capillary blood as an alternative strategy for TDM in patients treated with the newly antiepileptic drug. Our method is suitable for TDM, and this study suggests that VAMS allows monitoring of cenobamate concentration and can offer valuable support for personalized therapy in refractory epilepsy.
Year:
2024
Background: Human milk oligosaccharides (HMOs), which are unique bioactive components in human milk, are increasingly recognized for their multifaceted roles in infant health. A deeper understanding of the nexus between HMOs and the gut–brain axis can revolutionize neonatal nutrition and neurodevelopmental strategies. Methods: We performed a narrative review using PubMed, Embase, and Google Scholar to source relevant articles. The focus was on studies detailing the influence of HMOs on the gut and brain systems, especially in neonates. Articles were subsequently synthesized based on their exploration into the effects and mechanisms of HMOs on these interconnected systems. Results: HMOs significantly influence the neonatal gut–brain axis. Specific concentrations of HMO, measured 1 and 6 months after birth, would seem to agree with this hypothesis. HMOs are shown to influence gut microbiota composition and enhance neurotransmitter production, which are crucial for brain development. For instance, 2′-fucosyllactose has been demonstrated to support cognitive development by fostering beneficial gut bacteria that produce essential short-chain fatty acids. Conclusions: HMOs serve as crucial modulators of the neonatal gut–brain axis, underscoring their importance in infant nutrition and neurodevelopment. Their dual role in shaping the infant gut while influencing brain function presents them as potential game-changers in neonatal health strategies.
Year:
2024
Background Developmental and Epileptic Encephalopathies (DEEs) are defined by drug-resistant seizures and neurodevelopmental disorders. Over 50% of patients have a genetic cause. Studies have shown that patients with DEEs, regardless of genetic diagnosis, experience a central visual function disorder known as Cerebral (cortical) Visual Impairment (CVI). The prevalence of CVI in DEE patients is currently unknown. A quantitative synthesis of existing data on prevalence rates of this condition would aid in understanding the magnitude of the problem, outlining future research, and suggesting the need for therapeutic strategies for early identification and prevention of the disorder. Methods This systematic review and meta-analysis protocol adheres to the PRISMA-P statement and utilizes the JBI Manual for Evidence Synthesis, focusing on the prevalence of cerebral visual impairments in patients with developmental and epileptic encephalopathy. Eligibility criteria are established following the CoCoPop framework. Comprehensive database searches will include MEDLINE, EMBASE, Science Direct, Scopus, PsychINFO, Wiley, Highwire Press, and the Cochrane Library of Systematic Reviews. The risk of bias will be assessed using the JBI Critical Appraisal Checklist for Studies reporting prevalence data. Heterogeneity will be evaluated using Cochran’s Q statistic and the I2 statistic. Summary tables and narrative text will present characteristics of the included studies. Pooled prevalence estimates will be calculated using a random-effects model and presented graphically in forest plots. If heterogeneity is high, a narrative summary will be provided. The quality of evidence will be assessed using the GRADE methodology. Discussion This protocol outlines a systematic review and meta-analysis that aims to identify, collect, evaluate, and integrate epidemiological knowledge related to the prevalence of CVI in patients with DEEs. To the best of our knowledge, no other systematic review and meta-analysis has addressed this specific issue. The results will provide useful information for understanding the extent of the problem, outlining future research, and suggesting the need for early identification strategies. Systematic review registrations: This Systematic Review Protocol was registered in PROSPERO (CRD42023448910).
Year:
2024
Objective DYNC1H1 variants are involved on a disease spectrum from neuromuscular disorders to neurodevelopmental disorders. DYNC1H1 ‐related epilepsy has been reported in small cohorts. We dissect the electroclinical features of 34 patients harboring de novo DYNC1H1 pathogenic variants, identify subphenotypes on the DYNC1H1 ‐related epilepsy spectrum, and compare the genotype–phenotype correlations observed in our cohort with the literature. Methods Patients harboring de novo DYNC1H1 pathogenic variants were recruited through international collaborations. Clinical data were retrospectively collected. Latent class analysis was performed to identify subphenotypes. Multivariable binary logistic regression analysis was applied to investigate the association with DYNC1H1 protein domains. Results DYNC1H1 ‐related epilepsy presented with infantile epileptic spasms syndrome (IESS) in 17 subjects (50%), and in 25% of these individuals the epileptic phenotype evolved into Lennox–Gastaut syndrome (LGS). In 12 patients (35%), focal onset epilepsy was defined. In two patients, the epileptic phenotype consisted of generalized myoclonic epilepsy, with a progressive phenotype in one individual harboring a frameshift variant. In approximately 60% of our cohort, seizures were drug‐resistant. Malformations of cortical development were noticed in 79% of our patients, mostly on the lissencephaly–pachygyria spectrum, particularly with posterior predominance in a half of them. Midline and infratentorial abnormalities were additionally reported in 45% and 27% of subjects. We have identified three main classes of subphenotypes on the DYNC1H1 ‐related epilepsy spectrum. Significance We propose a classification in which pathogenic de novo DYNC1H1 variants feature drug‐resistant IESS in half of cases with potential evolution to LGS (Class 1), developmental and epileptic encephalopathy other than IESS and LGS (Class 2), or less severe focal or genetic generalized epilepsy including a progressive phenotype (Class 3). We observed an association between stalk domain variants and Class 1 phenotypes. The variants p.Arg309His and p.Arg1962His were common and associated with Class 1 subphenotype in our cohort. These findings may aid genetic counseling of patients with DYNC1H1‐ related epilepsy.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Collaborators (61)
Niels K. Focke
-
Federica Pigliasco
Istituto Giannina Gaslini
Christian Rummel
Professor AI Medical Systems
Deggendorf Institute of Technology
Luis Concha
Professor
National Autonomous University of Mexico
Benjamin Bender
University Hospital
Rikke S. Møller
University of Southern Denmark
Antonio Gambardella
Professor of Neurology
Università degli Studi Mediterranea di Reggio Calabria
Mariasavina Severino
IRCCS Istituto Giannina Gaslini
Justyna Paprocka
Medical University of Silesia
Terence O'Brien
MONASH UNIVERSITY
Clara Franziska Weber
Max Planck Institute for Human Cognitive and Brain Sciences
Carlo Di Bonaventura
-
Julie Absil
Hôpital Erasme
Laura Canafoglia
MD, PhD
Fondazione IRCCS Istituto Neurologico Carlo Besta
John S Duncan
University College London
Theodor Rüber
University Hospital Bonn
Lorenzo Caciagli
PI
University of Pennsylvania
Ezequiel Gleichgerrcht
Assistant Professor
Emory University
Ziv Gan-Or
Montreal Neurological Institute and Hospital
Orrin Devinsky
Professor of Neurosurgery, Psychiatry, and Neurology
NYU School of Medicine
Mark Philip Richardson
King’s College London
Matthias Kirschner
University of Geneva
Sara Larivière
Assistant Professor
Université de Sherbrooke
Gianpiero Cavalleri
Professor of Human Genetics
-
Heath Pardoe
Associate Professor
MONASH UNIVERSITY
Casey Paquola
Young Investigator Group Leader
Forschungszentrum Jülich
Patricia Desmond
head
University of Melbourne
Sanjay Sisodiya
University College London
Peter Taylor
UKRI Future Leaders Fellow / Professor
Newcastle University
Maria Eugenia Caligiuri
Professore Associato
-
Leonardo Bonilha
University of South Carolina
Simon Keller
Chair
University of Liverpool
Allan Bayat
University of Southern Denmark
Rhys Thomas
Reader in Epilepsy
Newcastle University Faculty of Medical Sciences
Patrick Kwan
-
Fernando Cendes
Full Professor
University of Campinas
Lucy Vivash
MONASH UNIVERSITY
Edward Boyd
Assistant Professor-Research
Michigan State University
Birgit Frauscher
Professor
Duke University
Colin Doherty
Prof.
Trinity College Dublin
Stefano Meletti
Direttore
-
Emanuele Cerulli Irelli
Sapienza University of Rome
Eric Yu
McGill University
Vijay Tiwari
The Queen's University Belfast
Domenica Immacolata BATTAGLIA
Professore Associato (dal 2017)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Gavin Winston
Professor of Neurology
Queen's University
Richard T. Ngomba
University of Lincoln
Alessia Cafaro
Health Researcher
Istituto Giannina Gaslini
Laura Licchetta
University of Bologna
Georgia Ramantani
Dozentin
University of Zurich
Dewi Schrader
Clinical Assistant Professor, Paediatric Neurologist
-
Clarissa Yasuda
Associate Professor
University of Campinas
Raffaele Falsaperla
Docenti di ruolo di IIa fascia
University of Ferrara
Martin Domin
Senior researcher
University Medicine Greifswald
Boris C. Bernhardt
Associate Professor
McGill University
Anna Elisabetta Vaudano
University of Modena and Reggio Emilia
Angelo Labate
Full Professor of Neurology
University of Messina
Renzo Guerrini
AOU Meyer
Francesco Fortunato
Ricercatori a tempo determinato
Magna Graecia University
Marian Galovic
Head of Epilepsy Unit, Consultant Neurologist
University of Zurich
Antonietta Coppola
-
Make your next move.
Prepare your application
Review drafts before you send them.